Key result
A-to-G changes observed in SARS-COV-2 genomes represent genuine RNA editing events, likely mediated by ADAR1, which are distributed along the viral genome and are mostly nonsynonymous.
Why the study?
Recent investigations based on metatranscriptomic samples of COVID-19 patients and SARS-COV-2-infected Vero cells have yielded contrasting findings regarding ADAR1-mediated RNA deamination.
Supports host-driven SARS-CoV-2 evolution; leaves open whether ADAR1 targeting alters clinical outcomes.
ADAR1-mediated deamination of adenosines in long double-stranded RNAs plays an important role in modulating the innate immune response. However, recent investigations based on metatranscriptomic samples of COVID-19 patients and SARS-COV-2-infected Vero cells have recovered contrasting findings. Using RNAseq data from time course experiments of infected human cell lines and transcriptome data from Vero cells and clinical samples, we prove that A-to-G changes observed in SARS-COV-2 genomes represent genuine RNA editing events, likely mediated by ADAR1. While the A-to-I editing rate is generally low, changes are distributed along the entire viral genome, are overrepresented in exonic regions, and are (in the majority of cases) nonsynonymous. The impact of RNA editing on virus-host interactions could be relevant to identify potential targets for therapeutic interventions.
No takes yet. Share an insight, caveat, or question.
Picardi et al. (2021) studied SARS-COV-2 infection. SARS-COV-2 infection vs. Uninfected cells was evaluated on Detection of A-to-I RNA editing events (A-to-G changes). A-to-G changes observed in SARS-COV-2 genomes represent genuine RNA editing events, likely mediated by ADAR1, which are distributed along the viral genome and are mostly nonsynonymous.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: